Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Plasma Olanzapine in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 1999-2009PATEL, Maxine X ; BOWSKILL, Sally ; COUCHMAN, Lewis ; LAY, Victoria ; TAYLOR, David ; PATHROSE SPENCER, Edgar ; FLANAGAN, Robert JamesJournal of clinical psychopharmacology, 2011-08, Vol.31 (4), p.411-417 [Peer Reviewed Journal]Hagerstown, MD: Lippincott Williams & WilkinsFull text available |
2 |
Material Type: Article
|
![]() |
Olanzapine-Related Somnambulism: A Systematic Review of Literature and a Case Report of Anorexia Nervosade Filippis, Renato ; Guinart, Daniel ; Rania, Marianna ; Carbone, Elvira Anna ; Gaetano, Raffaele ; Segura-Garcia, CristinaJournal of clinical psychopharmacology, 2021-11, Vol.41 (6), p.658-666 [Peer Reviewed Journal]United StatesFull text available |
3 |
Material Type: Article
|
![]() |
Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept StudyHunt, Hazel J ; Donaldson, Kirsteen ; Strem, Mark ; Tudor, Iulia Cristina ; Sweet-Smith, Suzanne ; Sidhu, SharanJournal of clinical psychopharmacology, 2021-11, Vol.41 (6), p.632-637 [Peer Reviewed Journal]United States: Lippincott Williams & WilkinsFull text available |
4 |
Material Type: Article
|
![]() |
Effects of Dose, Age, Sex, Body Weight, and Smoking on Plasma Concentrations of Olanzapine and N-desmethyl Olanzapine in Inpatients With SchizophreniaAn, Huimei ; Fan, Hongzhen ; Chen, Song ; Qi, Siyuan ; Ma, Botao ; Shi, Jing ; Wang, Zhiren ; Yang, FudeJournal of clinical psychopharmacology, 2021-05, Vol.41 (3), p.255-259 [Peer Reviewed Journal]United StatesFull text available |
5 |
Material Type: Article
|
![]() |
Age Impacts Olanzapine Exposure Differently During Use of Oral Versus Long-Acting Injectable Formulations: An Observational Study Including 8,288 PatientsTveito, Marit ; Smith, Robert L ; Molden, Espen ; Haslemo, Tore ; Refsum, Helge ; Hartberg, Cecilie ; Correll, Christoph U ; Høiseth, GudrunJournal of clinical psychopharmacology, 2018-12, Vol.38 (6), p.570-576 [Peer Reviewed Journal]United StatesFull text available |
6 |
Material Type: Article
|
![]() |
The Effect of Valproic Acid on Olanzapine Serum Concentration: A Study Including 2791 Patients Treated With Olanzapine Tablets or Long-Acting InjectionsTveito, Marit ; Smith, Robert Løvsletten ; Høiseth, Gudrun ; Molden, EspenJournal of clinical psychopharmacology, 2019-11, Vol.39 (6), p.561-566 [Peer Reviewed Journal]United StatesFull text available |
7 |
Material Type: Article
|
![]() |
Real-World Effectiveness of High-Dose Olanzapine and Clozapine for Treatment-Resistant Schizophrenia in Japan: A Retrospective Bidirectional Mirror-Image StudyWatanabe, Maiko ; Misawa, Fuminari ; Takeuchi, HiroyoshiJournal of clinical psychopharmacology, 2024-03, Vol.44 (2), p.151-156 [Peer Reviewed Journal]United StatesFull text available |
8 |
Material Type: Article
|
![]() |
Fenofibrate ameliorates olanzapine's side effects without altering its central effect: emphasis on FGF-21-adiponectin axisGalal, Aya ; El-Bakly, Wesam M ; El-Kilany, Sara S ; Ali, Azza A ; El-Demerdash, EbtehalBehavioural pharmacology, 2021-12, Vol.32 (8), p.615-629 [Peer Reviewed Journal]EnglandNo full-text |
9 |
Material Type: Article
|
![]() |
In Reply: Olanzapine for Chemotherapy-induced Nausea and Vomiting Pediatric Population: Take Home Message?Meena, Jagdish Prasad ; Gupta, Aditya Kumar ; Jat, Kana RamJournal of pediatric hematology/oncology, 2024-05, Vol.46 (4), p.216-216 [Peer Reviewed Journal]United StatesFull text available |
10 |
Material Type: Article
|
![]() |
Analysis of the correlation between clinical efficacy and blood concentration of olanzapine in schizophrenia patientsYuan, Mei ; Yuan, Bo-Zhi ; Wu, JiangMedicine (Baltimore), 2023-03, Vol.102 (10), p.e32912-e32912 [Peer Reviewed Journal]United States: Lippincott Williams & WilkinsFull text available |